Transient inhibition of type I interferon enhances CD8+ T cell stemness and vaccine protection
Transient inhibition of type I interferon enhances CD8+ T cell stemness and vaccine protection
Developing vaccines that promote CD8+ T cell memory is a challenge for infectious disease and cancer immunotherapy. TCF-1+ stem cell-like memory T (TSCM) cells are important determinants of long-lived memory. Yet, the developmental requirements for TSCM formation are unclear. Here, we identify the temporal window for type I interferon (IFN-I) receptor (IFNAR) blockade to drive TSCM cell generation. TSCM cells were transcriptionally distinct and emerged from a transitional precursor of exhausted (TPEX) cellular state concomitant with viral clearance. TSCM differentiation correlated with T cell retention within the lymph node paracortex, due to increased CXCR3 chemokine abundance which disrupted gradient formation. These affects were due a counterintuitive increase in IFNγ, which controlled cell location. Combining IFNAR inhibition with mRNA-LNP vaccination promoted specific TSCM differentiation and enhanced protection against chronic infection. These finding propose a new approach to vaccine design whereby modulation of inflammation promotes memory formation and function.
Broomfield Benjamin J、Duckworth Brigette C、Mackiewicz Liana、Muramatsu Hiromi、Pellegrini Marc、Nutt Stephen L、Davis Melissa J、Wimmer Verena、Groom Joanna R、Tan Chin Wee、Moon Woohyun J、Qin Raymond Z、Dalit Lennard、Alvarado Carolina、Rogers Kelly、Pardi Norbert、Chen Jinjin
基础医学生物科学研究方法、生物科学研究技术
Broomfield Benjamin J,Duckworth Brigette C,Mackiewicz Liana,Muramatsu Hiromi,Pellegrini Marc,Nutt Stephen L,Davis Melissa J,Wimmer Verena,Groom Joanna R,Tan Chin Wee,Moon Woohyun J,Qin Raymond Z,Dalit Lennard,Alvarado Carolina,Rogers Kelly,Pardi Norbert,Chen Jinjin.Transient inhibition of type I interferon enhances CD8+ T cell stemness and vaccine protection[EB/OL].(2025-03-28)[2025-05-04].https://www.biorxiv.org/content/10.1101/2024.06.26.600763.点此复制
评论